⌘K

07:00:00·1511d

PRReleasevia Quantisnow

Agios Reports Business Highlights and First Quarter 2022 Financial Results

ByQuantisnow·Wall Street's wire, on your screen.

AGIO· Agios Pharmaceuticals Inc.

Health Care

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Ballal Rahul D. converted options into 2,816 shares, increasing direct ownership by 23% to 15,230 units (SEC Form 4)
Director Capello Jeffrey D converted options into 2,816 shares, increasing direct ownership by 35% to 10,865 units (SEC Form 4)
Director Foster-Cheek Kaye I converted options into 2,816 shares, increasing direct ownership by 38% to 10,284 units (SEC Form 4)
Director Fouse Jacqualyn A converted options into 2,816 shares, increasing direct ownership by 2% to 154,156 units (SEC Form 4)
Director Ho Maykin converted options into 2,816 shares, increasing direct ownership by 17% to 19,848 units (SEC Form 4)